Bevacizumab/Paclitaxel/Topotecan Regimen

Preferred Label : Bevacizumab/Paclitaxel/Topotecan Regimen;

NCIt synonyms : Hycamtin/Taxol/Avastin Regimen; Hycamtin-Taxol-Avastin Regimen; Topotecan-Paclitaxel-Bevacizumab; Topotecan/Paclitaxel/Bevacizumab; Topotecan-Paclitaxel-Bevacizumab Regimen; PACLTOPO BEVA Regimen; TPB Regimen; Topotecan/Paclitaxel/Bevacizumab Regimen;

NCIt related terms : Paclitaxel, Topotecan, Bevacizumab;

NCIt definition : A regimen consisting of topotecan, paclitaxel and bevacizumab that is used for the treatment of cervical cancer.;

NCI Metathesaurus CUI : CL523553;

Codes from synonyms : 11554;

Details

Origin ID

C136242;

UMLS CUI

C4526516;

Est indiqué pour
- Metastatic Cervical Carcinoma [NCIt concept]
- Recurrent Cervical Carcinoma [NCIt concept]
- Refractory Cervical Carcinoma [NCIt concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Paclitaxel [NCIt concept]
- Topotecan Hydrochloride [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Cervical Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients